Gilberto Torres
Physician Assistant · Oklahoma City, OKNPI 1982677654
Payments from drug & device makers
Across 295 payments — averaging $18.26 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Otsuka America Pharmaceutical, Inc.$1K
- AbbVie$628
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$587
- Teva Pharmaceuticals USA, Inc.$510
- Johnson & Johnson$506
- Almatica Pharma LLC$407
- plus $2K from 12 others
What the payments were for
- Food & beverage$5,27598%
- Education$1112%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 58 | $1,106 |
| AbbVie | 43 | $628 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 29 | $587 |
| Teva Pharmaceuticals USA, Inc. | 29 | $510 |
| Johnson & Johnson | 31 | $506 |
| Almatica Pharma LLC | 22 | $407 |
| Takeda Pharmaceuticals U.S.A., Inc. | 17 | $372 |
| Alkermes, Inc. | 17 | $340 |
| Indivior Inc. | 18 | $300 |
| Lundbeck LLC | 11 | $230 |
| Neurocrine Biosciences, Inc. | 6 | $95 |
| Axsome Therapeutics, Inc. | 4 | $94 |
| Corium, LLC | 3 | $68 |
| Sunovion Pharmaceuticals Inc. | 2 | $44 |
| Supernus Pharmaceuticals, Inc. | 2 | $34 |
| E.r. Squibb & Sons, L.L.C. | 1 | $24 |
| Idorsia Pharmaceuticals US Inc | 1 | $23 |
| Sun Pharmaceutical Industries Inc. | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$5,387 in reported general payments places this provider in the 90th percentile of 1,491 physician assistant providers in Oklahoma.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Invega SustennaPaliperidone Palmitate | 58 | $200,848 |
| IngrezzaValbenazine Tosylate | 12 | $89,828 |
| PerserisRisperidone | 25 | $75,776 |
| RexultiBrexpiprazole | 16 | $21,965 |
| Aripiprazole | 219 | $12,445 |
| Paliperidone ErPaliperidone | 39 | $9,268 |
| Olanzapine | 355 | $8,327 |
| TrintellixVortioxetine Hydrobromide | 13 | $6,970 |
| Haloperidol | 86 | $5,503 |
| Quetiapine Fumarate | 187 | $4,502 |
| Divalproex Sodium ErDivalproex Sodium | 60 | $3,370 |
| Ziprasidone Hcl | 75 | $3,240 |
| Risperidone | 125 | $3,147 |
| Venlafaxine Hcl ErVenlafaxine Hcl | 88 | $2,842 |
| Trazodone Hcl | 211 | $2,711 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Johnson & JohnsonInvega Sustenna | $506 | $200,84858 claims |
| Neurocrine Biosciences, Inc.Ingrezza | $95 | $89,82812 claims |
| Indivior Inc.Perseris | $300 | $75,77625 claims |
| Otsuka America Pharmaceutical, Inc.Rexulti | $1,106 | $21,96516 claims |
| Takeda Pharmaceuticals U.S.A., Inc.Trintellix | $372 | $6,97013 claims |
| Almatica Pharma LLCSertraline Hcl | $407 | $1,855161 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 1,491 physician assistant providers in Oklahoma.
Other physician assistant in Oklahoma City
- Jennifer SmithOklahoma City$134K
- Sarah HawkOklahoma City$23K
- Brooke CromerOklahoma City$14K
- Mary Jane RorickOklahoma City$14K
- Alma HintzeOklahoma City$14K
- Emily McLainOklahoma City$13K
- Deniz AktasOklahoma City$13K
- Jovonne SmithOklahoma City$12K
- Anthony SharpOklahoma City$11K
- Whitney PriceOklahoma City$11K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.